Un nouveau type de collaboration on-line : tu accèdes à mes données cliniques (Pfizer) et je t’offre mon réseau social de médecins (Sermo) !
On ne mesure pas bien en Europe ce qu’un réseau social peut apporter à l’exercice de la médecine. Pourtant on commence (un peu, à peine ?) à connaître les réseaux sociaux : 
)
Qu’est ce qu’un “réseau social”? C’est un site qui permet de réunir une communauté sociale et de créer des liens entre les fiches ou minisites des membres, les premiers exemples sont LinkedIn.com, FaceBook.com et MySpace.com
Qu’est ce que Sermo ? La première et plus importante communauté on-line ou réseau social de médecins aux US. De nombreux usages collaboratifs sont possibles et nous allons assister au passage de la mise en réseau des connaisances (Web 2.0) à la mise en réseau des pratiques (Web 2.1 ou 3.0 ?). Pour ceux que cela passionne voir le post d’Esther DYSON (Top Gourou) dans le fameux huffingtonpost (LE blog d’info qui dépasse les médias traditionnels) sur la question, apres la fantastique conférence Health 2.0, totalement passionnant !!!!
Pourquoi Pfizer ?
Réponse marketing : parce que le leader mondial doit innover pour rester leader mondial ! Le communiqué de presse de Pfizer est ci-dessous. Pfizer est très actif on-line et a déja lancé un web chanel sur FORA.
Pfizer and Sermo the nation’s largest online physician community, today announced a strategic collaboration designed to redefine the way physicians in the U.S. and the healthcare industry work together to improve patient care.Sermo is a Web-based community where physicians share observations from daily practice, discuss emerging trends and provide new insights into medications, devices and treatments.
Through this collaboration, Sermo’s community of physicians will have access to Pfizer’s clinical content in tangible ways that allow for the transparent and efficient exchange of knowledge.
With access to comprehensive and up-to-date information on Pfizer products, physicians will be able to find the data they need, when they need it, to make informed decisions.
This collaboration reflects Pfizer’s commitment to engaging in peer-to-peer medical dialogue with physicians to better meet our mutual goal of delivering the best care to patients, said Michael Berelowitz, MD, Senior Vice President of Global Medical and New York Site Head of Worldwide Development for Pfizer.Sermo’s state of the art technology has the potential to greatly improve our ability to provide physicians with timely and accurate information they want about our medicines and clinical data.Pfizer, working together with Sermo’s physician community and other Sermo partners, plans to pursue a number of key objectives through this collaboration, including:
- Discover, with physicians, how best to transform the way medical information is exchanged in the fast-moving social media environment
- Create an open and transparent discussion with physicians through the innovative channel offered by online exchange
- Engage with the FDA to define guidelines for the use of social media in communications with healthcare professionals
- Work with physicians to develop a productive exchange between pharmaceutical professionals and the Sermo community
“Sermo has quickly become a powerful voice in the U.S. and physicians want that voice to be heard by parties best positioned to take action,” said Daniel Palestrant, MD, CEO of Sermo.“Our physician community has asked Sermo to find new ways to work closer with industry, building on our work with the American Medical Association and the U.S. Food & Drug Administration. Pfizer has chosen to assume a leadership role and find common ground with physicians in this environment built on trust and defined by transparency.”
